Sickle cell disease pathophysiology: From theoretical to practical aspects;Physiopathologie de la drépanocytose, de la théorie aux aspects pratiques

Revue du Praticien

Volumn 54, Issue 14, 2004, Pages 1534-1542

  Galactéros, Frédéric ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA GLOBIN; CELL ADHESION MOLECULE; HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA; LACTATE DEHYDROGENASE; MAGNESIUM; NITRIC OXIDE;

ALPHA THALASSEMIA; BETA THALASSEMIA; BLOOD VESSEL OCCLUSION; EMBOLISM; HUMAN; HYPOXEMIA; INFARCTION; METABOLIC ACIDOSIS; PATHOPHYSIOLOGY; PHENOTYPE; POLYMERIZATION; PRIAPISM; REVIEW; SICKLE CELL ANEMIA; THEORETICAL STUDY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANEMIA, SICKLE CELL; CHRONIC DISEASE; GENETIC PREDISPOSITION TO DISEASE; HEMOLYSIS; HUMANS;

EID: 4744344041     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Ósarogiagbon UR, Choong S, Belcher JD et al. reperfusion injury pathophysiology in sickle transqenic mice. Blood 2000; 96: 314-20.
2. Morris CR, Kuypers FA, Larkin S et al. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 2000; 22: 515-20.
3. Eaton WA, Hofrichter J. Hemoglobin S qelation and sickle cell disease. Blood 1987; 70: 1245-66.
4. Eaton WA, Hofrichter J. Sickle cell hemoglobin polymerization. Adv Prot Chem 1990; 40: 63-79.
5. Serjeant GR, Serjeant BE, Milner FF. The irreversibly sickled cell; a determinant of hemolysis in sickle cell anemia. Br J Haematol 1969; 17: 527-33.
6. Kaul DK, Chen D, Zhan J. Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells. Blood 1994; 83: 3006-17.
7. Franco RS, Yasin Z, Lohmann JM et al. The survival characteristics of dense sickle cells. Blood 2000; 96: 3610-7.
8. Brugnara C, de Franchesci L, Alper SL. Inhibition of Ca (2+)-dependent K + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993; 95: 520-6.
9. Weiner DL, Hibberd PL, Betit P et al. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 2003; 289: 1136-42.
10. Romoro JR, Suzuka SM, Nagel RL et al. Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity. Blood 2002; 99: 1103-8.
11. Brugnara C, Van Ha T, Tosteson DC. Acid pH induces formation of dense cells in sickle erythrocytes. Blood 1989; 47: 487-95.
12. Franco RS, Lohmann J, Silberstein EB et al. Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest 1998; 101: 2730-40.
13. de Franchesci L, Bachir D, Galacteros F et al. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1997; 100: 1847-52.
14. Hebbel RP, Boogaerts MA, Eaton JW et al. Erythrocyte adherence to endothelium in sickle cell anemia a possible determinant of disease severity. N Engl J Med 1980; 302: 992-5.
15. Hillery CA, Du MC, Montgomery RR, Scott JP. Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of e red blood cell lipid that binds thrombospondin and laminin. Blood 1996; 87: 4879-86.
16. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 2000; 106: 411-20.
17. Belcher JD, Marker PH, Weber JP et al. Activated monocytes in sickle cell disease potential role in the activation of vascular endothelium and vaso-occlusion. Blood 2000; 96: 2451-9.
18. Graido-Gonzalez E, Doherty JC, Bergreen EW et al. Plasma endothelin-1, cytokine and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 1998; 92: 2551-5.
19. Platt OS, Brambilla DJ, Rosse WF et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-44.
20. Miller ST, Sleeper U, Pegelow CH et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000; 342: 83-9.
21. Adler BK, Salzman DE, Carabasi MH et al. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood 2001; 97: 3313-4.
22. Wun T, Paglieroni T, Field CL et al. Platelet-erythrocyte adhesion in sickle cell disease. J Invest Med 1999; 47: 121-7.